HPLC method validation and pharmacokinetic study of alendronate sodium in human urine with fluorescence detection

Journal of Liquid Chromatography and Related Technologies

Volumn 29, Issue 11, 2006, Pages 1589-1600

  Kang, Hyun Suk ^a   Hwang, Sung Joo ^a   Park, Jeong Sook ^a   Kim, Chong Kook ^b  

^a Chungnam National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Alendronate sodium; Fluorescence detection; HPLC; Human urine

Indexed keywords

CONCENTRATION (PROCESS); FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH EFFECTS; PHARMACOKINETICS; PRECIPITATION (CHEMICAL);

ALENDRONATE SODIUM; FLUORESCENCE DETECTION; HUMAN URINE; SOLID PHASE EXTRACTION (SPE);

MEDICINE;

9 FLUORENYLMETHYL CHLOROFORMATE; ACETONITRILE; ALENDRONIC ACID; CITRIC ACID; DIETHYLAMINE; METHANOL; PAMIDRONIC ACID; PYROPHOSPHATE; SODIUM CARBONATE; SODIUM HYDROXIDE;

ARTICLE; DERIVATIZATION; DRUG EXCRETION; DRUG STRUCTURE; DRUG URINE LEVEL; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRECIPITATION; REPRODUCIBILITY; SOLID PHASE EXTRACTION; VALIDATION PROCESS;

EID: 33646490407     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070600678308     Document Type: Article

References (16)

1. Russell, R.G.; Rogers, M.J. Bisphosphonates: From the laboratory to the clinic and back again. Bone 1999, 25 (1), 97-106.
2. Hosking, D.; Chilvers, C.E.; Christiansen, C.; Ravn, P.; Wasnich, R.; Ross, P.; McClung, M.; Balske, A.; Thompson, D.; Daley, M.; Yates, A.J. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N. Engl. J. Med. 1998, 338 (8), 485-492.
3. Fleisch, H. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 1991, 42 (6), 919-944.
4. Fitton, A.; McTavish, D. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 1991, 41 (2), 289-318.
5. Ptáček, P.; Klíma, J.; Macek, J. Determination of alendronate in human urine as 9-fluorenylmethyl derivative by high-performance liquid chromatography. J. Chromatogr. B 2002, 767 (1), 111-116.
6. Lovdahl, M.J.; Pietrzyk, D.J. Anion-exchange separation and determination of bisphosphonates and related analytes by post-column indirect fluorescence detection. J. Chromatogr. A 1999, 850 (1-2), 143-152.
7. Han, Y.H.R.; Qin, X.Z. Determination of alendronate sodium by ion chromatography with refractive index detection. J. Chromatogr. A 1996, 719 (2), 345-352.
8. Tsai, E.W.; Ip, D.P.; Brooks, M.A. Determination of alendronate in pharmaceutical dosage formulations by ion chromatography with conductivity detection. J. Chromatogr. A 1992, 596 (2), 217-224.
9. Qin, X.Z.; Tsai, E.W.; Sakuma, T.; Ip, D.P. Pharmaceutical application of liquid chromatography-mass spectrometry: II. Ion chromatography-ion spray mass spectrometric characterization of alendronate. J. Chromatogr. A 1994, 686 (2), 205-212.
10. De Marco, J.D.; Biffar, S.E.; Reed, D.G.; Brooks, M.A. The determination of 4-amino-1-hydroxybutane-1,1-diphosphonic acid monosodium salt trihydrate in pharmaceutical dosage forms by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 1989, 7 (12), 1719-1727.
11. Lin, J.H. Bisphosphonates: a review of their pharmacokinetic properties. Bone 1996, 18 (2), 75-85.
12. Al Deeb, S.K.; Hamdan, I.I.; Al Najjar, S.M. Spectroscopic and HPLC methods for the determination of alendronate in tablets and urine. Talanta 2004, 64 (3), 695-702.
13. Yun, M.H.; Kwon, K.I. High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: Application to a pharmacokinetic study in humans. J. Pharm. Biomed. Anal. 2006, 40 (1), 168-172.
14. Lee, Y.J.; Kim, Y.G.; Lee, M.G.; Chung, S.J.; Lee, M.H.; Shim, C.K. Analysis of bioequivalence study using log-transformed model. Yakhakhoeji. 2000, 44 (4), 308-314.
15. Park, J.S.; Park, K.M.; Kim, C.K. Determination of triflusal in human plasma by high performance liquid chromatography with automated column switching system. J. Liq. Chromatogr. & Rel. Technol. 2000, 23 (16), 2513-2524.
16. Jeal, W.; Barradell, L.B.; McTavish, D. Alendronate. A review of its pharmacological properties and therapeutic efficacy in postmenopausal osteoporosis. Drugs 1997, 53 (3), 415-434.